Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 臨床・診断
  • リプロダクティブ・ヘルス
    • リプロダクティブ・ヘルス
    • 感染症
    • がん
    • 自己免疫(powered by Euroimmun)
    • 内分泌学
    • アレルギー
    • 神経変性
    • ラピッド検査
  • 出生前検査
    • 出生前検査
    • Reproductive Health Data Management
    • Revvity Genomics Software
    • 新生児スクリーニング
    • Newborn Sequencing Research
    • Pregnancy-Relevant Infections
    • Endocrine Reproductive
    • cell-free DNA解析
    • Neonatal Research
    • Preimplantation Genetic Testing
    • PlGF Testing Research
    • 分子細胞遺伝学
  • Biochemical Prenatal Testing
    • Biochemical Prenatal Testing
    • Preeclampsia Testing
    • Vanadis NIPT System

Biochemical Prenatal Testing

Tailored solutions to support your screening needs

When it comes to risk assessment and diagnosis of prenatal aneuploidy, early detection is essential. Clinically validated assays, combined with one of three scalable technology platforms and our Lifecycle ™ software for risk calculation, laboratories and clinics can achieve optimized screening performance while maximizing operational efficiency.

Whatever your preferred biochemical screening model, our assays offer tailored solutions for screening needs in the first and second trimester.


Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals. 

For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.

biochemical-prenatal-testing872x872
  • Quick links
  • Solutions
  • Applications
  • Resources
  • Contact support

Solutions for 1st and 2nd trimester:

  • 1T Quad – accurate results even without NT (Nuchal Translucency)
  • 1T DBS – Dried Blood Spot assays with same clinical performance as serum assays
  • 2T Double
  • 2T Triple
  • 2T Quad
  • 2T AFP – for neural tube defect screening

1st trimester

In the first trimester, our four CE-marked assays – PAPP-A, free hCGß, PlGF and AFP – provide effective screening for aneuploidy. Additionally, the PlGF marker can be used for preeclampsia screening from a single sample. Our dried blood spot assays provide the same clinical performance as first trimester serum assays and supports easier access to screening in regions where storage of serum samples can be a challenge.

In the first trimester, our four CE-marked assays – PAPP-A, free hCGß, PlGF and AFP – provide effective screening for aneuploidy. Additionally, the PlGF marker can be used for preeclampsia screening from a single sample. Our dried blood spot assays provide the same clinical performance as first trimester serum assays and supports easier access to screening in regions where storage of serum samples can be a challenge.

2nd trimester

In the second trimester, our assay solutions enable you to run the cost-effective Double test or enhance your screening performance using the Triple test or 2T QUAD test. The human alpha-fetoprotein (AFP) marker offered as part of the first trimester Down syndrome screening panel can also be used for neural tube defect screening in the second trimester.

In the second trimester, our assay solutions enable you to run the cost-effective Double test or enhance your screening performance using the Triple test or 2T QUAD test. The human alpha-fetoprotein (AFP) marker offered as part of the first trimester Down syndrome screening panel can also be used for neural tube defect screening in the second trimester.

Risk assessment

The Lifecycle™ software provides a complete data management solution for your laboratory, but at its heart is our Risk Calculation Engine. It has been designed to perform multiple complex algorithms and manage a variety of screening models. The software is also user-configurable, meaning users can enter their own parameters based on MoM values to optimize performance for the local population.

The Lifecycle™ software provides a complete data management solution for your laboratory, but at its heart is our Risk Calculation Engine. It has been designed to perform multiple complex algorithms and manage a variety of screening models. The software is also user-configurable, meaning users can enter their own parameters based on MoM values to optimize performance for the local population.

Explore our biochemical prenatal & preeclampsia testing applications

biochemical-prenatal-preeclampsia-testing-instruments-512.png

Biochemical Prenatal & Preeclampsia Testing Instruments

Take advantage of the high analytical sensitivity of DELFIA® chemistry with your choice

Learn more | View products
RevvityKitBoxProductImage

Biochemical Prenatal & Preeclampsia Testing Kits

Revvity offers a comprehensive range of prenatal and pre-eclampsia assays with high analytical sensitivity of the DELFIA® chemistry.

Learn more | View products
risk-calculation-software-512x288.jpg

Risk Calculation Software

We offer complete solutions to monitor both maternal and fetal health during pregnancy. We have dedicated software for risk calculation both for prenatal and pre-eclampsia screening.

Learn more
prenatal_disorders

Pregnancy Complications

We deliver complete screening solutions for a wide range of pregnancy complications – and more than 9 million prenatal risk assessments are done every year using those tests.

Learn more
全てを表示 View less

Featured resources

Brochure

DELFIA Prenatal Screening Solutions Brochure

Learn more
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.